Politicians
Bills
House Bill 2355
117th Congress(2021-2022)
Opioid Prescription Verification Act of 2021
Active
Active
Passed House on Dec 8, 2021
Overview
Text
Introduced
Apr 5, 2021
Latest Action
Dec 9, 2021
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
2355
Congress
117
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Republican
Rodney Davis
Illinois
Republican
Doug LaMalfa
California
Republican
Gus Bilirakis
Florida
Republican
Scott Franklin
Florida
Republican
Adam Kinzinger
Illinois
Republican
Ann Wagner
Missouri
Republican
Ted Budd
North Carolina
Republican
Mike Turner
Ohio
Republican
Alex Mooney
West Virginia
House Votes (2)
Senate Votes (0)
Passed
December 9, 2021
Type
Final Passage Under Suspension Of The Rules Results
House Roll Call Votes
Summary

Opioid Prescription Verification Act of 2021

This bill modifies overdose prevention activities carried out by the Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC).

Specifically, HHS must update pharmacist training materials to include information about how to verify the identity of individuals who pick up prescribed medications.

In addition, the CDC may give preference, in awarding grants for overdose prevention, to states that

  • maintain a prescription drug monitoring program that mandates the collection of specified information, and
  • require dispensers of certain potentially addictive drugs to verify the identity of individuals who pick up prescribed medications.
Text (4)
Referred in Senate
December 9, 2021
Engrossed in House
December 8, 2021
Reported in House
November 30, 2021
Introduced in House
April 5, 2021
Actions (17)
12/09/2021
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
12/08/2021
Motion to reconsider laid on the table Agreed to without objection.
12/08/2021
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 410 - 15 (Roll no. 422). (consideration: CR H7540-7541)
12/08/2021
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 410 - 15 (Roll no. 422).(consideration: CR H7540-7541)
11/30/2021
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
11/30/2021
DEBATE - The House proceeded with forty minutes of debate on H.R. 2355.
11/30/2021
Considered under suspension of the rules. (consideration: CR H6691-6693; text: CR H6691)
11/30/2021
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
11/30/2021
Placed on the Union Calendar, Calendar No. 130.
11/30/2021
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-180.
07/21/2021
Ordered to be Reported (Amended) by Voice Vote.
07/21/2021
Committee Consideration and Mark-up Session Held.
07/15/2021
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
07/15/2021
Subcommittee Consideration and Mark-up Session Held.
04/13/2021
Referred to the Subcommittee on Health.
04/05/2021
Referred to the House Committee on Energy and Commerce.
04/05/2021
Introduced in House
Public Record
Record Created
Apr 6, 2021 7:12:13 AM
Record Updated
Mar 4, 2022 1:12:19 AM
Copyright © 2022 Civic Bits LLC
Privacy Policy
Terms of Service
What's New
About